Fig. 6From: Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage modelCellular expressions of inflammation in brain hemorrhagic zone by day 28 after ICH induction. A–D Illustrating the immunofluorescent (IF) microscopic finding (400 ×) for identification of cellular expression of CD68 (green color). E Analytical result of number of CD68+ cells, *versus other groups with different symbols (†, ‡, §), p < 0.0001. F–I Illustrating the IF microscopic finding (400 ×) for identification of cellular expression of CD11b (green color). J Analytical result of number of CD11b+ cells, *versus other groups with different symbols (†, ‡, §), p < 0.0001. Scale bar in right lower corner represents 20 µm. HPF = high-power field. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple comparison post hoc test (n = 6 for each group). Symbols [(*, †, ‡, §) indicate significance (at 0.05 level). IA = intra-carotid arterial administration; IV intravenous (i.e., tail vein) administration; SC = sham control; ICH = intracranial hemorrhage; Ir-MNa-hUC-MSC = ironic magnetic nanoparticles/human umbilical cord-derived mesenchymal stem cellsBack to article page